02157.HK
Lepu Biopharma Co., Ltd.
HKSE · Healthcare · Biotechnology · CN
HKD 4.35
+0.69%Margins
Gross margin
83.0%
EBITDA margin
2.4%
EBIT margin
-5.7%
Net margin
3.9%
FCF margin
-4.9%
4.7%
Return on equity
2.1%
Return on assets
-3.7%
Return on invested capital
0.54x
Asset turnover
-HKD 44.9M
Cash from operations
HKD 0.52
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026